James M Gallo, PharmD, PhD

img_James M Gallo
ADJUNCT PROFESSOR | Pharmacological Sciences
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT)
Systems Pharmacology of Brain Tumors
Our lab is focused on pharmacokinetic [PK]- and pharmacodynamic [PD]-directed brain tumor chemotherapy. We have incorporated systems-based methods with PK/PD methods to derive cell-type specific PK/PD and enhanced PD models that link PK and PD information at the cell and molecular scale. Ongoing projects concern anticancer drug discovery and development, oncometabolites, epigenetic modulators and tumor heterogeneity. The projects utilize a diverse array of methods that allow us to build mechanistic PK/PD models of anticancer drugs that they are scalable from preclinical models to patients. The ultimate objective of our work is to discover new targets and drugs and means to optimize multi-drug chemotherapeutic regimens.

For more information, please visit the Gallo laboratory website.

B.S., Massachusetts College of Pharmacy

Pharm.D., University of Florida

Ph.D., University of Arizona

2015

New award

ASCPT

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Gallo has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.